Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAssiut University

About this trial

In this study the investigators aim to compare the effect of the suprascapular- supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on analgesic effect during arthroscopic shoulder surgery, as postoperative pain scores ,postoperative consumption of analgesic rescue medications and diaphragmatic excursion assessment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

ASA status 1,2.

Age 18 years or older

Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively.

Disqualifiers

• Patient refusal

Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease.

Use of drugs that act on the autonomic nervous system (including β- blockers).

Coagulation disorders..

Trial design

Design model

Parallel

Treatments tested in this trial

  • Shoulder arthroscopy blocks

    Procedure/Surgery

    Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Interscalene block in shoulder arthroscopyActive comparator 1 intervention
Group B: Combined Supraclavicular block and suprascapular block in shoulder arthroscopyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative analgesia by visual analog scale (VAS).

The primary outcome of this study will be to evaluate and compare between suprascapular-supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on postoperative analgesia by vas score during 48h postoperatively ( 2h , 6h , 12h, 24h and 48h). The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

Time frame
48 hours

Secondary outcomes

1

Diaphragmatic excursion

Assessment of diaphragmatic excursion by ultrasound preoperatively and 1hour postoperatively

Time frame
1hour postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.